These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 16216098

  • 1. Infection with Fasciola hepatica.
    Aksoy DY, Kerimoglu U, Oto A, Erguven S, Arslan S, Unal S, Batman F, Bayraktar Y.
    Clin Microbiol Infect; 2005 Nov; 11(11):859-61. PubMed ID: 16216098
    [Abstract] [Full Text] [Related]

  • 2. Compartive studies on the effect of bithionol, praziqantel and triclabendazole in rabbit's fascioliasis. 1. Parasitological studies.
    el-Sayad MH.
    J Egypt Soc Parasitol; 1997 Apr; 27(1):131-42. PubMed ID: 9097534
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human fascioliasis.
    Saba R, Korkmaz M, Inan D, Mamikoğlu L, Turhan O, Günseren F, Cevikol C, Kabaalioğlu A.
    Clin Microbiol Infect; 2004 May; 10(5):385-7. PubMed ID: 15113313
    [Abstract] [Full Text] [Related]

  • 5. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS, Brodie SB, Weller PF.
    Clin Infect Dis; 2001 Jul 01; 33(1):1-5. PubMed ID: 11389487
    [Abstract] [Full Text] [Related]

  • 6. Indirect evidence of ectopic pancreatic fascioliasis in a human.
    Lee OJ, Kim TH.
    J Gastroenterol Hepatol; 2006 Oct 01; 21(10):1631-3. PubMed ID: 16928233
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
    Keiser J, Utzinger J, Vennerstrom JL, Dong Y, Brennan G, Fairweather I.
    Trans R Soc Trop Med Hyg; 2007 Dec 01; 101(12):1219-22. PubMed ID: 17905370
    [Abstract] [Full Text] [Related]

  • 9. [Hepatic fascioliasis in children: uncommon clinical manifestations].
    Almendras-Jaramillo M, Rivera-Medina J, Seijas-Mogrovejo J, Almendras-Jaramillo K.
    Arq Gastroenterol; 1997 Dec 01; 34(4):241-7. PubMed ID: 9629320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recurrent eosinophilic panniculitis associated with Fasciola hepatica infection.
    Perez C, Vives R, Montes M, Ostiz S.
    J Am Acad Dermatol; 2000 May 01; 42(5 Pt 2):900-2. PubMed ID: 10767701
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
    Walker SM, McKinstry B, Boray JC, Brennan GP, Trudgett A, Hoey EM, Fletcher H, Fairweather I.
    Parasitol Res; 2004 Dec 01; 94(6):427-38. PubMed ID: 15517388
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Systemic vasculitis associated with Fasciola hepatica infection.
    Llanos C, Soto L, Sabugo F, Gallegos I, Valenzuela O, Verdaguer J, Cuchacovich M.
    Scand J Rheumatol; 2006 Dec 01; 35(2):143-6. PubMed ID: 16641050
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.